Investor Relations
Press Releases

Press Releases

Press Releases

August 6, 2020
Proteostasis Therapeutics Reports Second Quarter 2020 Financial Results
BOSTON , Aug. 6, 2020 /PRNewswire/ --  Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced financial results for the second quarter ended June

Shareholder Tools